Immuneering IMRX
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 6.58 | 118.77 | -0.07 | -13,753 | -12 | |
| 2025Q3 | 7.00 | 102.78 | -0.38 | -15,381 | -15 | |
| 2025Q2 | 3.37 | 102.24 | -0.40 | -14,758 | -14 | |
| 2025Q1 | 1.52 | 102.92 | -0.42 | -15,485 | -15 | |
| 2024Q4 | 2.20 | 102.81 | -0.59 | -18,558 | -18 | |
| 2024Q3 | 2.49 | 104.63 | -0.49 | -15,274 | -15 | |
| 2024Q2 | 1.28 | 105.92 | -0.47 | -14,914 | -14 | |
| 2024Q1 | 2.89 | 107.11 | -0.49 | -15,326 | -14 | |
| 2023Q4 | 7.35 | 108.07 | -0.52 | -16,302 | -15 | |
| 2023Q3 | 7.68 | 110.57 | -0.42 | -13,926 | -13 | |
| 2023Q2 | 10.14 | 110.80 | -0.43 | -13,505 | -12 | |
| 2023Q1 | 9.71 | 107.90 | -0.51 | -14,680 | -14 | |
| 2022Q4 | 4.85 | 105.58 | -0.50 | -13,985 | -13 | |
| 2022Q3 | 14.32 | 102.68 | -0.48 | -13,188 | -13 | |
| 2022Q2 | 5.41 | 101.03 | -0.44 | -11,646 | -12 | |
| 2022Q1 | 6.47 | 100.22 | -0.49 | -12,926 | -13 | |
| 2021Q4 | 16.17 | 100.22 | -0.05 | -11,116 | -11 | |
| 2021Q3 | 26.55 | 100.11 | 0.46 | -8,543 | -9 | |
| 2021Q2 | 100.04 | -1.61 | -7,991 | -8 | ||
| 2021Q1 | 100.10 | -1.26 | -6,236 | -6 |